Match!

Autocrine/paracrine actions of growth hormone in human melanoma cell lines.

Published on Mar 1, 2020in Biochemistry and biophysics reports
· DOI :10.1016/J.BBREP.2019.100716
Ashiya Buckels2
Estimated H-index: 2
(UAB: University of Alabama at Birmingham),
Yue Zhang15
Estimated H-index: 15
(UAB: University of Alabama at Birmingham)
+ 4 AuthorsStuart J. Frank45
Estimated H-index: 45
(UAB: University of Alabama at Birmingham)
Sources
Abstract
Abstract Melanoma is the most aggressive skin cancer. Its aggressiveness is most commonly attributed to ERK pathway mutations leading to constitutive signaling. Though initial tumor regression results from targeting this pathway, resistance often emerges. Interestingly, interrogation of the NCI-60 database indicates high growth hormone receptor (GHR) expression in melanoma cell lines. To further characterize melanoma, we tested responsiveness to human growth hormone (GH). GH treatment resulted in GHR signaling and increased invasion and migration, which was inhibited by a GHR monoclonal antibody (mAb) antagonist in WM35, SK-MEL 5, SK-MEL 28 and SK-MEL 119 cell lines. We also detected GH in the conditioned medium (CM) of human melanoma cell lines. GHR, JAK2 and STAT5 were basally phosphorylated in these cell lines, consistent with autocrine/paracrine GH production. Together, our results suggest that melanomas are enriched in GHR and produce GH that acts in an autocrine/paracrine manner. We suggest that GHR may constitute a therapeutic target in melanoma.
  • References (28)
  • Citations (1)
📖 Papers frequently viewed together
7 Authors (K.S. Sousa, ..., J. Perry)
28 Citations
20196.16Cancers
1 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References28
Newest
#1Beatriz Domingues (University of Porto)H-Index: 1
#2José Manuel Lopes (University of Porto)H-Index: 32
Last. Helena Pópulo (University of Porto)H-Index: 11
view all 4 authors...
: Melanoma represents the most aggressive and the deadliest form of skin cancer. Current therapeutic approaches include surgical resection, chemotherapy, photodynamic therapy, immunotherapy, biochemotherapy, and targeted therapy. The therapeutic strategy can include single agents or combined therapies, depending on the patient's health, stage, and location of the tumor. The efficiency of these treatments can be decreased due to the development of diverse resistance mechanisms. New therapeutic ta...
86 CitationsSource
#1Christine WasingerH-Index: 3
#2Alexandra Hofer (TU Wien: Vienna University of Technology)H-Index: 5
Last. Martin HoheneggerH-Index: 23
view all 4 authors...
Cancer cells rewire metabolism to sustain high proliferation rates. Beside glycolysis and glutaminolysis, amino acids substitute as energy source, feed fatty acid biosynthesis and represent part of the secretome of transformed cells, including melanoma. We have therefore investigated acetate, pyruvate and the amino acid composition of the secretome of human melanoma cells representing the early slow (WM35, WM278, WM793b and VM21) and metastatic fast (A375, 518a2, 6F and WM8) growth phase in orde...
2 CitationsSource
#1Helma Zecena (UCM: University of California, Merced)H-Index: 1
#2Daniel Myklatun Tveit (UCM: University of California, Merced)H-Index: 3
Last. Fabian V. Filipp (UCM: University of California, Merced)H-Index: 19
view all 13 authors...
Kinase inhibition in the mitogen activated protein kinase (MAPK) pathway is a standard therapy for cancer patients with activating BRAF mutations. However, the anti-tumorigenic effect and clinical benefit are only transient, and tumors are prone to treatment resistance and relapse. To elucidate mechanistic insights into drug resistance, we have established an in vitro cellular model of MAPK inhibitor resistance in malignant melanoma. The cellular model evolved in response to clinical dosage of t...
18 CitationsSource
#1Jo K. Perry (University of Auckland)H-Index: 19
#2Zheng-Sheng Wu (Anhui Medical University)H-Index: 20
Last. Peter E. Lobie (THU: Tsinghua University)H-Index: 12
view all 5 authors...
The growth hormone (GH) and insulin-like growth factor-1 (IGF1) axis is the key regulator of longitudinal growth, promoting postnatal bone and muscle growth. The available data suggest that GH expression by tumour cells is associated with the aetiology and progression of various cancers such as endometrial, breast, liver, prostate, and colon cancer. Accordingly there has been increased interest in targeting GH-mediated signal transduction in a therapeutic setting. Because GH has endocrine, autoc...
10 CitationsSource
#1Reetobrata Basu (OU: Ohio University)H-Index: 6
#2Nicholas Baumgaertel (OU: Ohio University)H-Index: 1
Last. John J. Kopchick (OU: Ohio University)H-Index: 67
view all 4 authors...
Melanoma remains one of the most therapy-resistant forms of human cancer despite recent introductions of highly efficacious targeted therapies. The intrinsic therapy resistance of human melanoma is largely due to abundant expression of a repertoire of xenobiotic efflux pumps of the ATP-binding cassette (ABC) transporter family. Here, we report that GH action is a key mediator of chemotherapeutic resistance in human melanoma cells. We investigated multiple ABC efflux pumps (ABCB1, ABCB5, ABCB8, A...
11 CitationsSource
#1Reetobrata Basu (OU: Ohio University)H-Index: 6
#2Shiyong Wu (OU: Ohio University)H-Index: 23
Last. John J. Kopchick (OU: Ohio University)H-Index: 67
view all 3 authors...
// Reetobrata Basu 1, 2 , Shiyong Wu 1, 2 , John J. Kopchick 1, 2, 3 1 Edison Biotechnology Institute, Ohio University, Athens, Ohio, USA 2 Molecular and Cell Biology Program, Ohio University, Athens, Ohio, USA 3 Ohio University Heritage College of Osteopathic Medicine, Athens, Ohio, USA Correspondence to: John J. Kopchick, email: kopchick@ohio.edu Keywords: growth hormone (GH), growth hormone receptor (GHR), melanoma, cancer, IGF-1 Received: November 04, 2016 Accepted: January 24, 2017 Publishe...
17 CitationsSource
#1Vera Chesnokova (Cedars-Sinai Medical Center)H-Index: 24
#2Svetlana Zonis (Cedars-Sinai Medical Center)H-Index: 12
Last. Shlomo Melmed (Cedars-Sinai Medical Center)H-Index: 94
view all 12 authors...
Abstract Growth hormone (GH) excess in acromegaly is associated with increased precancerous colon polyps and soft tissue adenomas, whereas short-stature humans harboring an inactivating GH receptor mutation do not develop cancer. We show that locally expressed colon GH is abundant in conditions predisposing to colon cancer and in colon adenocarcinoma-associated stromal fibroblasts. Administration of a GH receptor (GHR) blocker in acromegaly patients induced colon p53 and adenomatous polyposis co...
26 CitationsSource
: The year 2015 marked the 30th anniversary of National Cancer Institute's (NCI's) initial effort to establish a human cell line panel as the basis for discovering new cancer drugs. At its inception, the NCI-60 panel was a controversial departure, born of frustration with previous efforts that employed murine tumors and grounded in the hope that the biology of human tumors was diverse and somehow quite different than the murine leukemia used for the previous 30 years. And while the NCI-60 has no...
25 CitationsSource
#1Ram PrasadH-Index: 17
#2John C. KappesH-Index: 52
Last. Santosh K. KatiyarH-Index: 67
view all 3 authors...
// Ram Prasad 1 , John C. Kappes 2, 5, 6 , Santosh K. Katiyar 1, 3, 4, 5, 6 1 Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA 2 Departments of Medicine and Pathology, University of Alabama at Birmingham, Birmingham, AL, USA 3 Environmental Health Sciences, University of Alabama at Birmingham, Birmingham, AL, USA 4 Nutrition Obesity Research Center, University of Alabama at Birmingham, Birmingham, AL, USA 5 Comprehensive Cancer Center, University of Alabama at ...
19 CitationsSource
#1Su An (Kunming University of Science and Technology)H-Index: 7
#2Yang Yang (Kunming University of Science and Technology)H-Index: 8
Last. Tian-Rui Xu (Kunming University of Science and Technology)H-Index: 12
view all 6 authors...
The Ras-Raf-MEK-MAPK (mitogen-activated protein kinase)-signaling pathway plays a key role in the regulation of many cellular functions, including cell proliferation, differentiation and transformation, by transmitting signals from membrane receptors to various cytoplasmic and nuclear targets. One of the key components of this pathway is the serine/threonine protein kinase, Raf. The Raf family kinases (A-Raf, B-Raf and C-Raf) have been intensively studied since being identified in the early 1980...
14 CitationsSource
Cited By1
Newest
#1Xiaojue Zhu (Soochow University (Suzhou))H-Index: 1
#2Yonghao Li (Soochow University (Suzhou))H-Index: 1
Last. Changqing FuH-Index: 1
view all 4 authors...
Growth hormone receptor (GHR), a member of the class I cytokine receptor family, plays key roles in cancer progression. Recently, GHR has been reported to be associated with breast cancer development, but the molecular mechanism of GHR in this malignancy is not fully understood. To investigate this issue, we stably inhibited GHR in breast cancer cell lines, which were observed to reduce cell proliferation, tumor growth, and induction of apoptosis, and arrest the cell cycle arrest at the G1-S pha...
1 CitationsSource